Sustained Release Matrix Tablet Formulation and Assessment

Over the past three decades, there has been a growing focus on the development of oral sustained release drug delivery systems. This shift is largely due to the increasing costs and challenges associated with introducing new drugs, combined with a greater understanding of the therapeutic advantages of prolonged medication use. The primary goals for creating sustained release drug delivery systems include minimizing dosage amounts and frequency while ensuring consistent drug delivery. A sustained release dosage form is one that provides medication in a controlled manner over a predetermined duration, targeting either systemic circulation or a specific organ. ^[1][2]

Drug Delivery Systems ^[3]

Drug delivery systems can be categorized into two main types. These are: 

I. Conventional drug delivery system 

II. Modified drug delivery system

I. Conventional Drug Delivery Systems

Traditional drug delivery methods work well for most medications; however, some drugs exhibit unstable or dangerous characteristics, limited therapeutic ranges, or solubility issues. To ensure consistent plasma levels, a continuous administration approach for therapeutic agents is recommended. Sustained or controlled drug delivery systems, illustrated in Figure 1, can achieve this continuous delivery. These methods offer several advantages over conventional systems, such as enhanced efficacy, reduced toxicity, and increased convenience for patients.^[4][5]

Drawbacks of Traditional Drug Delivery:

• Conventional oral dosage forms often lack control over drug release, leading to the need for intermittent administration of high doses to achieve effective concentrations at the target site.
• Patient compliance can suffer due to the higher likelihood of missing doses, especially for drugs with short half-lives requiring frequent administration.
• The dosing regimen of conventional forms can result in fluctuating, unpredictable, and frequently sub-therapeutic plasma concentrations, which may cause significant side effects.
• Unavoidable variations in drug concentrations might lead to either under-medication or over-medication.
• Typical plasma concentration profiles often show peaks and valleys, complicating the achievement of steady-state conditions.
• Over-medication can result in harmful effects, especially for drugs with a low Therapeutic Index (TI).
• Various factors, including the physicochemical properties of the drugs, the presence of excipients, and physiological influences such as food intake, pH levels of the gastrointestinal tract, and gastrointestinal motility, can significantly affect drug absorption rates and effectiveness.^[6]

II. Modified Drug Delivery System :

Dosage forms can be designed to regulate the release of a drug over time following administration, for an extended duration, or directed to specific targets within the body. Adjustments in drug release are often made to enhance the drug's stability, safety, and effectiveness, improve the therapeutic outcomes of drug therapy, and increase patient compliance and ease of administration.^[7]

• Delayed Release: These regimens feature one or more immediate release units combined in a single dosage form to provide the medication at intervals.
• Extended Release: These pharmaceutical forms are designed to release the drug more slowly than usual at a set rate, effectively reducing the frequency of dosage by half.
• Repeat Action: Typically, these forms contain two doses of medication—one for immediate release and another for delayed release.
• Target Action: This method aims to concentrate or focus the drug's release in a specific area, tissue, or region of the body for enhanced absorption or drug activity. from conventional formulations.

Controlled Release

Controlled drug delivery refers to the administration of medication at a rate or location determined by the body’s needs or the patient’s condition over a specified duration.

Sustained Release

Sustained drug delivery can provide an initial dose needed for a normal therapeutic effect, followed by a gradual release of the medication in quantities adequate to maintain therapeutic effects for a designated period, typically ranging from 8 to 12 hours. The primary objective of this therapy is to attain a stable blood level that remains therapeutically effective and non-toxic for an extended period. Sustained release indicates a slow release of the drug over time, and it may or may not involve controlled release.

Advantages of Extended Release Dosing forms:

1. Drug treatment is brought under control.
2. The rate and amount of medication absorption can be altered.
3. There is less frequent drug administration.
4. It is possible to increase patient adherence.
5. It is possible to administer drugs in a way that is convenient.
6. Increasing the availability of medicine while using the lowest dose possible.
7. The safety margin for powerful medications can be raised.^[10]

Disadvantages of continuous release dosage forms include:

1. The treatment cannot be terminated quickly.
2. Reduced ability to change the dosage.
3. These formulations are created using average dosages. half-life of the body.
4. They are pricey.
5. Drug Selection for Oral Administration.

BIOLOGICAL FACTORS INFLUENCING RELEASE FROM MATRIX TABLET:

Biological half-life:

Absorption:

Metabolism:

Distribution:

Protein binding:

Margin of safety:

1) Biological half-life:

The simple theory of an oral SR formulation is to maintain therapeutic blood levels over an extended period of time. To achieve this, drug must enter into the blood circulation at almost the same rate at which it is eliminated. Each drug has its own characteristic related to elimination rate, which is the sum of all elimination processes, generally include metabolism, urinary excretion and all the process that permanently remove drug from the blood stream.

The ideal candidates for are drugs with a short half-life. Formulation for prolonged release. drugs that have a shorter half-life of less than two hours, such as that of levodopa are not good candidates for SR formulation. Medications that also having a half-life of over eight hours. because their impact is not well represented in the SR formulation, they are a bad candidate. already maintained. Phenytoin, Digoxin, and other examples.

2) Absorption:

The goal of creating an SR product is to manage the The pace at which drugs are released is significantly slower than the rate at which they are released. absorption. Assuming that the transit time of The majority of medications are absorbed in the GI tract's absorptive regions. The extreme half-life for absorption is between 8 and 12 hours. should last approximately 3–4 hours; any longer than that, the The possible absorptive dosage form will pass out. areas before the drug has been completely released. Therefore matches the lowest observable rate of absorption The rate is consistently between 0.17 and 0.23 hours, which results in between 80 and 95% of this. time span. It consequently acknowledges that the body absorbs the drug. should happen over the course of the day at a fairly consistent pace the whole length of the small intestine. When a substance is absorbed or transfer is limited to a by active transport SR preparation may be applied to certain areas of the intestine. detrimental to absorption.

3) Metabolism:

Reduce bioavailability from slow-release formulations The Drugs form, which is displayed, Those are far prior to being absorbed, it is metabolized in the lumen or elsewhere. The intestine's tissue may exhibit diminished bio disponibility from a dosage form that releases slowly. A drug that has low water solubility can be prepared as a sustained-release dose form. To accomplish this, several strategies for improvement.The drug's solubility following the enhancement solubleness It is possible to formulate a sustainable release. However the drug can crystallize during this process when the medicine is entering the systemic circulation, should be avoided and one should be careful of the prevention of the same.

4) Distribution:

The rate at which drugs are eliminated is largely determined by based on the obvious volume of distribution. Hence drugs with a large apparent volume of distribution, effect this medication's rate of elimination is think about whether or not the individual is a suitable candidate for oral SR medication system of delivery. For instance, chloroquine.

5) Protein interaction:

To obtain a pharmacological response that is not bound to the drug Prioritizing focus over bound medication is crucial. concentration and the degree to which all medications bind to it proteins in plasma and/or tissue. Drug binding to proteins demonstrating a key function in its therapeutic benefit in regardless of the kind of dosage form as extensive binding to raise the biological half-life by turning it into plasma and thereby The SR drug delivery method is not always necessary for every situation. this sort of medication.

6) Molecular size and diffusivity:

In a number of prolonged release methods The drug must spread out via rate-controlling membranes or matrix. A drug's capacity to diffuse through The term diffusivity, or diffusion, refers to membranes. Its molecular size determines whether or not it is a coefficient. A significant impact on the diffusivity value. The molecular size for polymers is represented by the letter 'D'. the weight of the diffusing species.

7) Safety margin:

The safety of a medicine usually depends on the The therapeutic index is the ratio of the therapeutic effect. The safer a drug is, the lower its index is. medication with a lower The therapeutic index is usually a bad choice for oral system for administering SR medications.^{[11][12][13][14]}

Physicochemical Factor :

a) Dosage quantity: Typically, one dose of medicine will contain roughly the amount of drug. The highest recommended dose for a conventi-onal is 500 mg to 1.0 g. dose form. The same criteria apply to sustainability as well. dose form for release. Substances with high the dosage size, which may occasionally be administered in several doses quantities or made into liquid systems. Another The margin of safety is consideration, which includes administering a high dose of a medication with a a limited therapeutic window.

b) Aqueous solubility, ionization, and pka: The majority of medications are either weak acids or bases. The drugs, though, that are still the same way they were penetrate lipid As a result, the compound's pka and membranes are listed below. It's crucial to have an absorptive connection with the environment. Because drug permeation that presents the drug in its original form The format is beneficial. The solubility in water Sadly, it will be reduced by switching to unmodified, more complex form. delivery systems that rely on diffusion or The solubility will be just as important as the dissolution. of the medication in an aqueous medium. These methods of administration The environment must have a shifting pH for it to work. the small intestine is more acidic than the stomach the impact of anything that is neutral. Phone The release procedure must: must be defined. Compounds with low solubility (less than 0.01 mg/mL) because their release over the is naturally maintained. The time trajectory of a dosage form in the GI tract will be restricted by the drug's dissolution. Thus, it is clear that The compound's solubility will be a bad choice. because the driving force for somewhat soluble drugs is The drug's concentration in the bloodstream is determined by diffusion. The solution will be inexpensive.

c) Partitioning Coefficient: To have a therapeutic impact elsewhere in the body The drug is administered to the gastrointestinal system, and its effects are felt throughout the body. must pass through a number of biological membranes. It is It's typical to think of these membranes as being lipidic, hence the partition coefficient of oil The solubility of a drug is a crucial factor in determining the efficacy of passing through the membrane barrier. Chemicals that are lipophilic in nature and have a high partition coefficient are not very water soluble and It persists longer in lipophilic tissue. In in the event of chemicals with extremely low partition Due to its coefficient, it is exceedingly hard to enter the the compound containing a membrane a very low partition coefficient, which leads to bad bioavailability. In addition, there are partitioning consequences. as well as diffusion via polymer membranes. The The selection of diffusion-limiting membranes is mostly determined by rely on the drug's partitioning properties.

d) Stability: The medications that are given orally are exposed to Both acid-base hydrolysis and enzymatic degradation. A medication in solid state will continue to degrade at a Consequently, this is the preferred composition at the lower rate. of delivery in problematic instances. for the dosage forms which are prone to breakdown in the stomach, systems that extend the time of delivery during the whole journey via the digestive system have advantages. This is also true for systems that delay. release until the medication takes its form in the lower the gut. Compounds that are unstable in low When the intestine exhibits reduced bioavailability, it may be a sign of it. given via a maintenance dosage form. This is since the majority of medications are delivered in the small intestine. ^{[11][12][15][16]}

Formulation :

A) Diffusion-based system: Drug transfer via the diffusion process molecules moving from an area of greater concentration to one of lower concentration one with a lower concentration. The movement of the medication J (in the ratio of the quantity of substance to the area of the membrane through which it travels over time. The direction of decreasing concentration is indicated by the following: The law of Fick.

J = - D dc/dx

D = the diffusion coefficient in terms of space/time

dc/dx = the change in concentration 'c' with distance 'x'

Generally speaking, when a water-insoluble membrane

If a core of drug is surrounded by it, the substance must spread through it. the drug release rate dm/dt across the membrane is described by the following equation: The equation is

dm/dt= ADK. C/L

Where, Area = A

K = Partition coefficient of the drug between the drug core and membrane

L= diffusion route length

C = Concentration discrepancy throughout the membrane.

1. Diffuse reservoir system: A polymeric material that is insoluble in water makes up this system. covering the heart of the medication. The medicine will divide into the membrane and the exchange with the outside world the particle or tablet is liquid. More medication will be introduced. into polymer, diffuse to the periphery, and exchange. to the surrounding media. The medication is released over time. put by diffusion process. Diagram of Diffusion is shown in Figure 1.

2. Diffusion Matrix type : A hard medication is disseminated into an insoluble matrix as well as the drug release rate, which typically depends the rate at which drugs diffuse and the rate at which solids dissolution. The appropriate conclusion has been reached by Higuchi. The drug release equation for this mechanism.

Q=D/T [2A – Cs] Cst ½

Which, Q = The drug's weight in grams that is released every unit area of the surface at any given time t.

The diffusion coefficient of the medication during its release is represented by D.

ε= matrix porosity.

The drug's solubility in the release medium is known as Cs. The matrix's tortuosity is represented by T.

The concentration of the drug in the tablet, expressed in grams per milliliter, is denoted by the letter A.

The following formula can be used to determine the release rate:

Release rate = AD/L = [C1-C2]

Where, Area = A

D = Diffusion coefficient

C1 = Medication concentration in the center

The concentration of the medication in the surrounding environment is represented by C2. Diffusion path length = L

Diagrammatic representation of diffusion in Figure 2 matrix system for continuous medication delivery.

B) Systems that maintain dissolution: This medication has a gradual dissolution rate. that are naturally maintained and have high lowers their water solubility and rate of dissolution by creating the right salt or derivative. In general, these systems are used in the production of enteric-coated dosage forms. Prevention of the effects of medications, such as those that damage the stomach like a coating that dissolves in natural or artificial environments. alkaline environments are used. This prevents the medicine from being released. from the dose form till it reaches the greater pH of the intestine.

a) Soluble reservoir system: With this method, the drug is coated in an erodible coating. which is gradually broken down by the contents of the digestive system by alternating layers of drug with the rate-controlling layer coats.

Figure 3: Diagrammatic representation of soluble reservoir system

b) System with a soluble matrix: It might be a drug or a drug-infused sphere. a tablet that will be impregnated and then slowly processed erosion.

Diagrammatic illustration of soluble is seen in figure 4. matrix system

C) Ion Exchange Methods: Ion exchange resin is an appealing method for prolonged medicine delivery as a characteristic of drug release primarily depends only on the ionic environment of less prone to drug-containing resins environmental factors such as enzyme composition and pH Zero-order release at the location of absorption kinetic may with this method, it can be achieved successfully. Delivery systems based on ion exchange are superior. strategy for a medication that is particularly vulnerable to enzymatic breakdown.

Resin for ion exchange which are classified by type:

a) Resins for cation exchange:

b) Anion exchange resin:

Cationic exchange resin: Includes acidic functional groups group They are often made up of polystyrene polymer. with any phenolic carboxylic phenolic group. Resin for anion exchange: Contains the fundamental functional group able to remove anions from acidic solutions. The impact of is maintained by ion exchange resins. a medicine based on the idea that it has either a positive or negative impact charge drug moiety mix with the proper resin The idea of generating insoluble poly salts strikes a chord.

Here, cationic and are represented by R-SO-H and R-NH–OH, respectively. In contrast, H N-A and HOOCB represent basic and acidic medicines, respectively, while anionic resin is represented by the former.

Where Resins that are taken orally interact with acids. liquids having a pH of 1.2 after containing HCl the response occurs:

R-SO3-H + + H2N-A → R-SO3 - + N3H In addition, the fact that the trial took place at the time of year when people are most likely to commit crimes also contributed to its occurrence.

-A N-R + H3OH- + HOOC-B -> R-N + Water and H3-00C-B+ After that, the system enters the intestine. where it is subjected to a fluid with a somewhat alkaline pH.

The following reaction happens:

R-SO3-H+ + H2N-AR-SO3 + H3N-A

R-N*H3OH + HOOC-B→ R-N*H3-00C-B+ H?O

Subsequently when the system reaches to intestine where it is exposed to a fluid of slightly alkaline pH.

Following reaction occurs:

R-SO³-H3N+A + HCI R-SO3-H++A-N*H3CI

R-N+H3-OOC-B + HCIR-N+H3Cl + B-COOH

R-SO3-H3N-A + NaCl→ R-SO3-Na*+ A-NH3Cl

R-N*H3-OOC-B + Nacl→ R-NH?CI + B-COO Na

D) pH-independent formulations: The oral route has undesirable features for some people. a system of management that extends the transit time by means of the gastrointestinal tract, which limits the length of prolongation extends the chemical environment throughout the gastrointestinal system is limitation on the design of dosage forms. Because the majority of medications The drug release from sustained release formulations is pH dependent since they are either weak acids or weak bases. Because keeping the pH consistent to assist in this pH rendering independent buffers for drug release, such as citric acid, phthalic acid, and amino acids are represented as salts. tartaric or phosphoric acid added to the formulation. The creation of buffered sustained release. The release formulation is usually made by combining a an alkaline or basic drug with one or more buffer(s) granulating with the proper medication coating with gastrointestinal fluid and excipients polymer that creates a permeable film. If The gastrointestinal liquid permeates the. The fluid is regulated by the buffering agents in the membrane. providing an appropriate, stable pH inside to make a consistent drug release rate.

E) Modified density recipes: If not all of the dosage form content is released into the GI tract treatise Then it is only useful in a limited way. In light of this, a number of methods have been created to extend the  length of time that a medicine delivery system stays in the body the digestive tract. The high-density strategy: The density of the pellets should be determined by this method. more than that of typical stomach contents and As a result, it should have a minimum density of 1–4 g/cm3. In anticipation of This kind of medicine may be applied to a thick core. or combined with dense, inert substances like barium. titanium dioxide sulfate , zinc oxide, and iron powder. Low-density strategy: spherical shells with a density less than that of use of stomach fluid as a drug carrier for prolonged effects the goal of the release popcorn, pop rice, and polystyrol are examples of this. The surface of this empty shell is used by everyone as a carrier. undercoated with sugar or polymer material like cellulose acetate and methacrylic polymer phthalate. The undercoated shell is then covered by a combination of a polymer, such as ethyl cellulose, and a medicine and Hydroxy propyl cellulose. Therefore, the end outcome floats in the gastric fluid for a long time, while releasing drugs slowly.